Related Experiment Video
Updated: Jun 10, 2026
06:48
CD Spectroscopy to Study DNA-Protein Interactions
Published on: February 10, 2022
Excursions in polynuclear platinum DNA binding
John B Mangrum1, Nicholas P Farrell
1Department of Chemistry, Virginia Commonwealth University, 1001 W. Main Street, Richmond, VA 23284, USA.
Chemical Communications (Cambridge, England)
|August 10, 2010
Summary
Polynuclear platinum agents, distinct from cisplatin, offer novel anti-cancer mechanisms. Research reveals unique DNA binding modes, including phosphate clamp interactions, expanding understanding of their therapeutic potential.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Structural Biology
Background:
- Polynuclear platinum agents represent a distinct class of anti-cancer drugs.
- Understanding their unique structure-activity relationships requires challenging existing paradigms.
Purpose of the Study:
- To explore the chemistry and biology of polynuclear platinum agents.
- To delineate the DNA binding modes and structural consequences of these agents.
- To describe novel DNA adducts formed by these compounds.
Main Methods:
- Utilized Nuclear Magnetic Resonance (NMR) spectroscopy for solution-state DNA structures.
- Employed X-ray crystallography for solid-state DNA structures.
- Applied Electrospray Ionization Mass Spectrometry (ESI-MS) for gas-phase analysis.
- Integrated molecular biology techniques to complement structural data.
Main Results:
- Characterized covalent and non-covalent DNA adducts induced by polynuclear platinum agents.
- Identified unprecedented DNA binding modes, including long-range major-groove interstrand crosslinks and directional isomers.
- Discovered a novel 'phosphate clamp' mode of ligand-DNA binding, distinct from minor-groove binding or intercalation.
Conclusions:
- Polynuclear platinum agents exhibit diverse and complex DNA binding mechanisms.
- The newly identified DNA adducts and binding modes offer new avenues for drug design.
- This research expands the understanding of anti-cancer drug-DNA interactions beyond established models.
Related Concept Videos
01:03Single-Strand DNA Binding Proteins
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
02:54Nucleosome Remodeling
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...